
Students open the door to medical innovation
A new science specialisation at Ullern Upper Secondary School will give students first-hand experience of medical research and innovation.

A new science specialisation at Ullern Upper Secondary School will give students first-hand experience of medical research and innovation.

From Tehran to Oslo, how one researcher is developing a new weapon against treatment-resistant cancers.

With offices in Norway, Sweden and Denmark, NordicRWE wants to strengthen collaboration on health data and cancer innovation.

A Centre of Excellence for personalised training before, during and after cancer has been established in Oslo Cancer Cluster Innovation Park.

Under Arendalsuka satte vi søkelyset på noen av de viktigste spørsmålene innen kreftforskning, innovasjon og helsepolitikk. Her kan du se samtalene i opptak.

Eksperter og politikere mente at klarere økonomiske insentiver til sykehusene er det viktigste tiltaket for å få flere kliniske studier til Norge.
Get monthly news updates and invitations to events from our oncology cluster.

Six new members have joined the board of Oslo Cancer Cluster, highlighting the need for more international collaboration, better framework conditions for innovation and commercialisation, and improved patient access.

A new pilot study in Bærum explores how easier access to sunscreen can improve children’s sun habits and help prevent skin cancer.

Siste uken på skolen før sommeren fikk alle elevene på andre trinn ved Ullern videregående skole oppleve en helt spesiell dag: Karrieredag. Her fikk de en innføring i hva de kan forvente seg av fremtidens arbeidsmarked, og møtte tidligere Ullern-elever og folk fra ulike yrker.

The Norwegian hub was recently formally approved as a national Cancer Mission Hub by the General Assembly of the EU project ECHoS. The Norwegian model received strong praise from European stakeholders currently establishing similar hubs, and Norway now has one of the 17 recognised hubs in Europe.

Ferd joins Oslo Science Hub, supporting the further development of the Radium Hospital Campus as a national hub for cancer research, innovation and industry.

International experts met in Oslo as the symposium EuSARC 2026 highlighted new sarcoma biology and innovative cancer therapies.

